Literature DB >> 32638779

Copper(ii) l/d-valine-(1,10-phen) complexes target human telomeric G-quadruplex motifs and promote site-specific DNA cleavage and cellular cytotoxicity.

Farukh Arjmand1, Surbhi Sharma1, Sabiha Parveen1, Loic Toupet2, Zhen Yu3, James Allan Cowan3.   

Abstract

Chiral l-/d-valine-(1,10-phen)-Cu(ii) complexes that target G-quadruplex DNA were synthesized and thoroughly characterized by UV-vis, IR, EPR, ESI-MS, elemental analysis and single crystal X-ray spectroscopy. Complexes 1a and 1b crystallized in the monoclinic P21/c and C2 space groups, respectively. On the basis of Wolfe-Shimer analyses, the binding affinities of 1a and 1b with G-quadruplex telomeric DNA were determined, and 1a exhibited significantly higher binding as compared to 1b. Site selective cleavage of G4-DNA was demonstrated by employing the time-dependent PAGE assay, with 1a exhibiting a significantly higher cleavage rate from A1 to G22 (4.32 (±0.13) μM h-1) than 1b (4.29 (±0.11) μM h-1). The DNA cleavage profile demonstrated that both complexes perform non-random double-strand cleavage by following first-order kinetics (kobs = 0.9432 min-1 for 1a and kobs = 0.6574 min-1 for 1b). Molecular docking simulations were performed with both parallel and anti-parallel topologies of the quadruplex to provide a clear insight on G-quadruplex-complex interactions. Complexes 1a and 1b were found to interact strongly at the minor groove cavity of the quadruplex with preferential selectivity for the parallel vs. anti-parallel quadruplex. The cytotoxic activities of complexes 1a and 1b were evaluated on a few notably important human cancer cell lines, viz, breast (MCF-7), pancreatic strains (BxPC3, AsPC1) and liver (Huh7) by an MTT assay. Both 1a and 1b exhibited pronounced cytotoxic activity with remarkably low IC50 values (1-3 μM) for all tested cancer strains.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32638779      PMCID: PMC7433390          DOI: 10.1039/d0dt01527j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  61 in total

1.  Python: a programming language for software integration and development.

Authors:  M F Sanner
Journal:  J Mol Graph Model       Date:  1999-02       Impact factor: 2.518

2.  Helix formation by guanylic acid.

Authors:  M GELLERT; M N LIPSETT; D R DAVIES
Journal:  Proc Natl Acad Sci U S A       Date:  1962-12-15       Impact factor: 11.205

3.  Enantiomeric copper based anticancer agents promoting sequence-selective cleavage of G-quadruplex telomeric DNA and non-random cleavage of plasmid DNA.

Authors:  Sabiha Parveen; J A Cowan; Zhen Yu; Farukh Arjmand
Journal:  Metallomics       Date:  2020-06-24       Impact factor: 4.526

4.  New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity.

Authors:  Siffeen Zehra; Mohammad Shavez Khan; Iqbal Ahmad; Farukh Arjmand
Journal:  J Biomol Struct Dyn       Date:  2018-05-07

5.  Role of the central metal ion and ligand charge in the DNA binding and modification by metallosalen complexes.

Authors:  S S Mandal; U Varshney; S Bhattacharya
Journal:  Bioconjug Chem       Date:  1997 Nov-Dec       Impact factor: 4.774

6.  Toward the design of a catalytic metallodrug: selective cleavage of G-quadruplex telomeric DNA by an anticancer copper-acridine-ATCUN complex.

Authors:  Zhen Yu; Menglu Han; James A Cowan
Journal:  Angew Chem Int Ed Engl       Date:  2014-12-11       Impact factor: 15.336

7.  Copper(II) Complexes of Phenanthroline and Histidine Containing Ligands: Synthesis, Characterization and Evaluation of their DNA Cleavage and Cytotoxic Activity.

Authors:  Sílvia M G Leite; Luís M P Lima; Sofia Gama; Filipa Mendes; Maylis Orio; Isabel Bento; António Paulo; Rita Delgado; Olga Iranzo
Journal:  Inorg Chem       Date:  2016-11-07       Impact factor: 5.165

Review 8.  Copper complexes as anticancer agents.

Authors:  Cristina Marzano; Maura Pellei; Francesco Tisato; Carlo Santini
Journal:  Anticancer Agents Med Chem       Date:  2009-02       Impact factor: 2.505

9.  A dinuclear ruthenium(ii) phototherapeutic that targets duplex and quadruplex DNA.

Authors:  Stuart A Archer; Ahtasham Raza; Fabian Dröge; Craig Robertson; Alexander J Auty; Dimitri Chekulaev; Julia A Weinstein; Theo Keane; Anthony J H M Meijer; John W Haycock; Sheila MacNeil; James A Thomas
Journal:  Chem Sci       Date:  2019-02-18       Impact factor: 9.825

Review 10.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822

View more
  3 in total

Review 1.  Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action.

Authors:  Sebastiano Masuri; Petr Vaňhara; Maria Grazia Cabiddu; Lukáš Moráň; Josef Havel; Enzo Cadoni; Tiziana Pivetta
Journal:  Molecules       Date:  2021-12-22       Impact factor: 4.411

2.  Interaction of Carrier Protein with Potential Metallic Drug Candidate N-Glycoside 'GATPT': Validation by Multi-Spectroscopic and Molecular Docking Approaches.

Authors:  Sabiha Parveen; Mohd Sajid Ali; Hamad A Al-Lohedan; Sartaj Tabassum
Journal:  Molecules       Date:  2021-11-02       Impact factor: 4.411

Review 3.  Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy.

Authors:  Marzieh Anjomshoa; Bagher Amirheidari
Journal:  Coord Chem Rev       Date:  2022-02-05       Impact factor: 22.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.